Form 4: Anterix CLO Executes Stock Options and Sells Shares
Statement of Changes in Beneficial Ownership
Anterix Inc. Chief Legal Officer Gena L. Ashe exercised stock options and sold a portion of the resulting shares.
Summary
- Gena L. Ashe, Chief Legal Officer & Corp Sec, exercised options for 11,000 shares at $34.96 and 18,368 shares at $49.39.
- A total of 15,657 shares were withheld by the company to cover exercise costs and tax obligations.
- The reporting person sold 17,711 shares in the open market at prices ranging from $81.00 to $82.14.
- Following these transactions, the reporting person holds 9,531 shares of Anterix common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transactions represent routine executive financial planning rather than a strategic shift or signal of company performance.
Positives
- The executive maintains a remaining direct ownership of 9,531 shares, indicating continued alignment with the company.
- The exercise of options demonstrates the executive's participation in the company's long-term equity incentive programs.
Negatives
- The transaction resulted in a net reduction of the executive's total beneficial ownership of company stock.
Risks
- Future share price volatility may impact the value of remaining equity holdings.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Industry Context
StockSavvy.ai notes that insider selling following option exercises is a standard practice for liquidity and tax management among corporate executives and does not necessarily reflect a change in sentiment regarding the company's long-term prospects.
Comparison to Industry Standards
- The use of cashless exercises to cover tax obligations is a standard corporate governance practice for executive compensation.
Stakeholder Impact
- Minimal impact on shareholders as the transactions were conducted by an individual executive for personal financial management.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 06/15/2026 | Date of earliest transaction involving option exercises and share sales. |
| 06/17/2026 | Date of filing for the reported transactions. |
Keywords
Anterix, ATEX, Insider Trading, Form 4, Stock Options, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.